AC Immune SA (ACIU) Form 6-K — May 15, 2026
AC Immune SA announced that founding CEO Dr. Andrea Pfeifer will retire after 23 years, with Board Chair Dr. Martin Zügel appointed as Interim CEO effective immediately. This leadership transition coincides with the company’s Annual General Meeting invitation, which includes proposals for board re-elections and compensation approvals.
Key figures
- Currency
- CHF
- Fiscal Year
- 2025
- Exec Compensation Max
- 6742000
- Board Compensation Max
- 1029000
- Capital Band Upper Limit
- 2862500
- Employee Benefit Shares
- 7500000
AI analysis
Red flags4 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.